|
I did such a search just out of curiosity. I had already learned that three babies in the Netherlands had died recently, at end-Oct / early-Nov 2009, after they were given this pneumococcal conjugate vaccine (PCV),
Also, I am familiar with data from Vaccine Adverse Events Reporting System (VAERS) - which include "coincidental" events as well as those truly caused by vaccines - that showed 28,317 adverse reactions since the Prevnar vaccine was approved in 2000. These included:
In addition, I had written in an earlier article about pneumonia vaccine side effects that the introduction of Prevnar and other pneumonia vaccines has led to:
So I was already quite familiar with the dangers and side effects of PCV vaccines like Prevnar. I was curious what was being claimed about the safety of Prevnar vaccine. So I did a search on Google. I found...
Prevnar vaccine insert
The Prevnar vaccine insert for doctors contains instructions, warnings, information about side effects etc. The insert warns, in big bold letters, that Prevnar® SHOULD UNDER NO CIRCUMSTANCES BE ADMINISTERED INTRAVENOUSLY. This means the vaccine should be injected into the muscles, and special care is needed to avoid injecting into, or near, a blood vessel or nerve. But with infants, whose blood vessels are fine and close together, and who might move about as they are being injected, it can be difficult to ensure this. So apart from the usual vaccine dangers, there is also the danger of human error. Adverse reactions listed in the insert are: As for the efficacy of the Prevnar vaccine, the insert reveals that it reduces the rate of Otitis Media (ear infection) by only 7 percent. Yet Prevnar is widely touted as a "vaccine for ear infections". |
And so on. There is just so much information about the side effects and dangers of the Prevnar vaccine. Why, then, do governments approve it?
How is vaccine safety determined?
Of course, there have been studies to determine the "safety" of the Prevnar vaccine. The main study was the Northern California Kaiser Permanente (NCKP) Prevnar Efficacy Trial conducted from October 1995 through August 20, 1998. The NCKP trial involved 37,816 infants who received either the Prevnar vaccine or a control vaccine at two, four, six and 12-15 months of age. Smaller scale follow-up studies were also conducted in Finland.
It is important to understand how these studies are conducted and how the "medical experts" decide whether a vaccine is safe. Without any background information, the average lay person would assume that if a vaccine has been declared to be "safe" it means that studies show it does not produce any serious side effects.
No so. In the case of the NCKP study, of the 17,066 subjects who received at least one dose of the Prevnar vaccine, the researchers recorded:
How can such serious side effects be considered acceptable?
Here's the interesting part. In normal drug trials, the experimental drug is compared to a placebo, a "dummy drug" that is usually made from sugar. In the case of a vaccine trial, however, the experimental vaccine is compared, not to a "dummy" but to another vaccine. As long as the experimental vaccine produces no worse side effects than the other vaccine, it is considered "safe".
There's more... The experimental vaccine does not even have to be compared to one that is already approved and known to be safe. In the NCKP study, the Prevnar vaccine was compared to another experimental vaccine, for meningitis. And it so happened that the other experimental vaccine produced even more deaths - although fewer of the other less serious side effects - than Prevnar. And so Prevnar was pronounced "safe".
Is death an acceptable side effect of vaccination?
Most doctors and government health authorities obviously think so. They look at cold statistics and tell us that a few deaths from vaccination are justified because it prevents even more deaths due to pneumonia. Such an argument ignores two important factors:
"Once you assume that a certain number of children are expendable, it is a very slippery slope. How many can you sacrifice? Is it five? Is it 100? Is it 5,000? It's very dangerous to employ that kind of utilitarian rationale,"" said Barbara Fisher, Co-founder & President of the US National Vaccine Information Center, in News 8 Investigates.
Of the Prevnar NCKP trial, Barbara Fisher said: "What's scientific about that? That every time something bad happens after vaccination it's 'coincidence'? That's not science, that's politics."
RELATED ARTICLES: